Lower expression of CD133 in SD patients might be linked also to a reduced CEP mobilization caused by metronomic chemotherapy [48, 49], and consequently to a better response to the therapy as CD133-positive cells are associated with chemoresistance [50]. The gene discussed is PROM1; the disease is Salla disease.